Skip to content

Safety and Efficacy of Carbon Dioxide Gas for Endoscopy

Safety and Efficacy of Carbon Dioxide Gas for Endoscopic Insufflation in Children

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06134154
Enrollment
350
Registered
2023-11-18
Start date
2024-01-24
Completion date
2028-12-01
Last updated
2026-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal Pain

Brief summary

The goal of this clinical trial is to compare the efficacy and safety of air versus carbon dioxide gas insufflation for endoscopy in children. The main question\[s\] it aims to answer are: •to determine safety of CO2 Assess patient comfort (abdominal pain, flatulence and bloating) with CO2 use when compared to air.

Detailed description

In this study, children (6 months -18 years) undergoing all endoscopic procedures that includes an upper endoscopy including but not limited to Esophagogastroduodenoscopy (EGD/ upper endoscopy), EGD/ Colonoscopy, Endoscopic Retrograde Cholangiopancreatography (ERCP), Endoscopic ultrasound (EUS) e.t.c after appropriate consent, will be randomized 1:1 to either Air or CO2 gas for endoscopic insufflation. We will record demographics (name, age, sex, MRN, race/ethnicity), anthropometrics including weight, height/length, weight for length (WFL), WFL z score, BMI, BMI z score, indication/ reason for scope, other co-morbidities (other medical problems), personnel involved (faculty only, vs faculty + trainee), minute by minute end tidal CO2 levels, minute by minute minute ventilation levels, baseline blood pCO2, and blood pCO2 after each procedure. Pre and post procedure patient reported abdominal pain, bloating and flatulence. Pre and post procedure nurse assessed pain. Pre and post procedure vital signs. Patients will be randomized using a sealed envelope method by the endoscopy technician. Both patients and providers will be blinded to arm of enrollment.

Interventions

OTHEREndoscopic insufflation gas

Carbon dioxide gas versus air for endoscopic insufflation

Sponsors

University of Alabama at Birmingham
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
6 Months to 18 Years
Healthy volunteers
No

Inclusion criteria

\- Infants and children 6 months to 18 years undergoing any upper endoscopy related procedure including but not limited to EGD/Colonoscopy, ERCP, EGD only, EUS, EGD with foreign body removal, Enteroscopy.

Exclusion criteria

* Patients with American Society of Anesthesiology (ASA) Physical Status Classification System of 4 and above * Children with chronic lung disease, * Children who are wards of the state will be excluded. * Children needing language interpreting services that is not Spanish.

Design outcomes

Primary

MeasureTime frameDescription
Abdominal Painbaseline/ pre-procedure to immediately after the procedureRates of abdominal pain from pre-procedure to immediately after the procedure

Secondary

MeasureTime frameDescription
PCO2 levelbaseline/ preprocedural to immediately after the procedureIncidence of elevated carbon dioxide level in the blood from pre-procedure to post -procedure

Countries

United States

Contacts

CONTACTChinenye R Dike, MD MS
cdike@uabmc.edu205 638 9918

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026